Filing Flows

Filing Flows › LifeStance Health Group (LFST) › Next earnings date

LifeStance Health Group (LFST) earnings: beat the estimate

LifeStance Health Group (LFST) reported on Nov 5, 2026 and beat the EPS estimate: $0.11 against $0.08 (+26.7%). Revenue was $456M for Q3 2026, +25% year over year. It beat the EPS estimate in 80% of the quarters on record.

Last result+26.7% vs estimate
Beat rate80%

The last report

LifeStance Health Group reported revenue of $456M for the third quarter 2026 (+25% Y/Y), net earnings $22.4M. How it makes money → · Every quarter →

LifeStance Health Group: EPS against the estimate, last 5 reportsLifeStance Health Group: EPS against the estimate, last 5 reportsEstimateReported$0.04$0.01Nov 25$0.05$0.09Feb 26$0.06$0.07May 26$0.08$0.11Aug 26$0.08$0.11Nov 26
Latest (Nov 26): Estimate $0.08, Reported $0.11.

LifeStance Health Group's latest quarter

LifeStance Health Group, Q3 2026: revenue $456M (+25% year over year), operating margin 7.3%, net earnings $22.4M, operating cash flow $37.0M. The chart follows the revenue to costs, profit and cash.

Questions

Did LifeStance Health Group beat earnings?

LifeStance Health Group (LFST) reported on Nov 5, 2026 and beat the EPS estimate: $0.11 against $0.08 (+26.7%).

When does LFST report earnings?

The next date is not set yet.

Does LifeStance Health Group usually beat earnings?

It beat the consensus EPS estimate in 80% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.